[go: up one dir, main page]

FR2771007B1 - COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE - Google Patents

COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE

Info

Publication number
FR2771007B1
FR2771007B1 FR9714322A FR9714322A FR2771007B1 FR 2771007 B1 FR2771007 B1 FR 2771007B1 FR 9714322 A FR9714322 A FR 9714322A FR 9714322 A FR9714322 A FR 9714322A FR 2771007 B1 FR2771007 B1 FR 2771007B1
Authority
FR
France
Prior art keywords
treatment
combination
active ingredients
senile dementia
alzheimer type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9714322A
Other languages
French (fr)
Other versions
FR2771007A1 (en
Inventor
Jean Pierre Maffrand
Philippe Soubrie
Jean Paul Terranova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9714322A priority Critical patent/FR2771007B1/en
Priority to CO98062479A priority patent/CO4980891A1/en
Priority to TW087117874A priority patent/TW585766B/en
Priority to TR2000/01262T priority patent/TR200001262T2/en
Priority to PL98340500A priority patent/PL194597B1/en
Priority to IDW20000860A priority patent/ID24933A/en
Priority to KR1020007005231A priority patent/KR100599350B1/en
Priority to AU11609/99A priority patent/AU743228B2/en
Priority to EA200000412A priority patent/EA003255B1/en
Priority to BR9814035-3A priority patent/BR9814035A/en
Priority to HU0100098A priority patent/HUP0100098A3/en
Priority to EP98954538A priority patent/EP1030671A1/en
Priority to PCT/FR1998/002384 priority patent/WO1999025363A1/en
Priority to EEP200000290A priority patent/EE04235B1/en
Priority to JP2000520796A priority patent/JP2001523642A/en
Priority to NZ504420A priority patent/NZ504420A/en
Priority to SK711-2000A priority patent/SK286040B6/en
Priority to IL13612298A priority patent/IL136122A0/en
Priority to CA002309966A priority patent/CA2309966A1/en
Priority to ARP980105661A priority patent/AR013750A1/en
Priority to CNB988130947A priority patent/CN1243540C/en
Priority to GT199800181A priority patent/GT199800181A/en
Priority to DZ980259A priority patent/DZ2649A1/en
Priority to UY25247A priority patent/UY25247A1/en
Priority to SA98190747A priority patent/SA98190747B1/en
Priority to MYPI98005180A priority patent/MY120461A/en
Publication of FR2771007A1 publication Critical patent/FR2771007A1/en
Priority to IS5482A priority patent/IS5482A/en
Priority to BG104428A priority patent/BG64819B1/en
Priority to NO20002450A priority patent/NO20002450L/en
Priority to OA1200000141A priority patent/OA11464A/en
Priority to IL136122A priority patent/IL136122A/en
Application granted granted Critical
Publication of FR2771007B1 publication Critical patent/FR2771007B1/en
Priority to US10/268,378 priority patent/US20030092737A1/en
Priority to US11/070,351 priority patent/US20050148614A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9714322A 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE Expired - Fee Related FR2771007B1 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
CO98062479A CO4980891A1 (en) 1997-11-14 1998-10-26 ASSOCIATION OF ACTIVE PRINCIPLES FOR THE TREATMENT OF SENILE DEMENTIA OF THE AZHEIMER TYPE
TW087117874A TW585766B (en) 1997-11-14 1998-10-28 Combination of active ingredients for the treatment of senile dementia of the Alzheimer type
CNB988130947A CN1243540C (en) 1997-11-14 1998-11-09 Combinations of active ingredients for the treatment of senile dementia of the Alzheimer's type
IDW20000860A ID24933A (en) 1997-11-14 1998-11-09 COMBINATION OF ACTIVE COMPONENTS FOR THE SENILE DEMENTIA TREATMENTS OF TYPES OF ALZHEIMER
KR1020007005231A KR100599350B1 (en) 1997-11-14 1998-11-09 Combinations of active ingredients for the treatment of senile dementia, such as Alzheimer's dementia, in particular tetrahydropyridines and acetylcholinesterase inhibitors
AU11609/99A AU743228B2 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as Alzheimer dementia
EA200000412A EA003255B1 (en) 1997-11-14 1998-11-09 Combination of tetrahydropyridin derivatives and acetylcholinesterase inhibiting agents for treating senile dementia such as alzheimer dementia
BR9814035-3A BR9814035A (en) 1997-11-14 1998-11-09 Association of active ingredients, notably tetrahydropyridines and acetylcholinesterase inhibiting agents, for the treatment of senile dementia of the alzheimer type.
HU0100098A HUP0100098A3 (en) 1997-11-14 1998-11-09 Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
EP98954538A EP1030671A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
PCT/FR1998/002384 WO1999025363A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
EEP200000290A EE04235B1 (en) 1997-11-14 1998-11-09 Combination of active substances, namely tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of the Alzheimer's disease type
JP2000520796A JP2001523642A (en) 1997-11-14 1998-11-09 Active ingredients for treating senile dementia such as Alzheimer's dementia, especially the combination of tetrahydropyridines and acetylcholinesterase inhibitors
NZ504420A NZ504420A (en) 1997-11-14 1998-11-09 Combination of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
SK711-2000A SK286040B6 (en) 1997-11-14 1998-11-09 Pharmaceutical composition containing 1-(2-napht-2-ylethyl)-4-(3- trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin hydrochloride and donepezil or tacrine
TR2000/01262T TR200001262T2 (en) 1997-11-14 1998-11-09 Combination of active ingredients for the treatment of Alzheimer's type senile dementia
CA002309966A CA2309966A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
ARP980105661A AR013750A1 (en) 1997-11-14 1998-11-09 ASSOCIATION OF ACTIVE PRINCIPLES FOR THE TREATMENT OF SENILE DEMENTIA OF ALZHEIMER TYPE
PL98340500A PL194597B1 (en) 1997-11-14 1998-11-09 Combination of active ingredients, in particular of tetrahydropyridines and acetylocholinesterases inhibiting agents, useful in treatment of senile dementia of alzheimer type
IL13612298A IL136122A0 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridines and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
GT199800181A GT199800181A (en) 1997-11-14 1998-11-10 ASSOCIATION OF ACTIVE PRINCIPLES FOR THE TREATMENT OF ALZHEIMER-TYPE SENILE DEMENTIA.
DZ980259A DZ2649A1 (en) 1997-11-14 1998-11-11 Association of active principles for the treatment of senile dementia of the alzheimer type.
UY25247A UY25247A1 (en) 1997-11-14 1998-11-12 ASSOCIATION OF ACTIVE PRINCIPLES FOR THE TREATMENT OF ALZHEIMER-TYPE SENILE DEMENTIA
SA98190747A SA98190747B1 (en) 1997-11-14 1998-11-14 A combination of active agents, particularly tetrahydropyridine and acetylcholinesterase inhibitors, for the treatment of senile dementia such as Alzheimer's
MYPI98005180A MY120461A (en) 1997-11-14 1998-11-14 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia.
IS5482A IS5482A (en) 1997-11-14 2000-05-09 Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia
NO20002450A NO20002450L (en) 1997-11-14 2000-05-11 Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type
BG104428A BG64819B1 (en) 1997-11-14 2000-05-11 Combination of tetrahydropyridins and acetylcholinesterase for treating senile dementia of alzheimer type
OA1200000141A OA11464A (en) 1997-11-14 2000-05-12 Combination of active principles, in particular oftetrahydropyridins and acetylcholinesterase inhib iting agents, for treating senile dementia such asAlzheimer dementia.
IL136122A IL136122A (en) 1997-11-14 2000-05-14 Combination of active principles, in particular of tetrahydropyridines and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
US10/268,378 US20030092737A1 (en) 1997-11-14 2002-10-10 Combination of active ingredients for the treatment of senile dementia of the Alzheimer type
US11/070,351 US20050148614A1 (en) 1997-11-14 2005-03-02 Combination of active ingredients for the treatment of senile dementia of the Alzheimer type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE

Publications (2)

Publication Number Publication Date
FR2771007A1 FR2771007A1 (en) 1999-05-21
FR2771007B1 true FR2771007B1 (en) 2000-12-01

Family

ID=9513397

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9714322A Expired - Fee Related FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE

Country Status (3)

Country Link
AR (1) AR013750A1 (en)
FR (1) FR2771007B1 (en)
GT (1) GT199800181A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
AR013750A1 (en) 2001-01-10
FR2771007A1 (en) 1999-05-21
GT199800181A (en) 2000-05-03

Similar Documents

Publication Publication Date Title
FR12C0077I2 (en) Composition for the treatment of genital warts
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
EP0670731A4 (en) TREATMENT OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY THE DEPOSITION OF AMYLOID G (B) PROTEIN.
DE69526684D1 (en) Aeration mixer for the treatment of molten metal
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
FR2705966B1 (en) Antifoam compositions useful in particular for the treatment of gastric disorders.
EP1126850A4 (en) TREATMENT OF CONDITIONS OF THE RETINA
DZ2649A1 (en) Association of active principles for the treatment of senile dementia of the alzheimer type.
NO20010456L (en) Triazolopyridines for the treatment of thrombosis disorders
EP1161255A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSERECTION
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
FR2684546B3 (en) TREATMENT INSTRUMENT, PARTICULARLY FOR THE COSMETIC TREATMENT OF THE FACE.
FR2758465B1 (en) COMPOSITION FOR THE TREATMENT OF ASBESTOS
MA23837A1 (en) BENZAMIDES FOR THE TREATMENT OF NEUROLOGICAL DEGENERES
ZA948176B (en) Compositions for the treatment of industrial water
DE69302799D1 (en) Composition for the treatment of boiler water
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
FR2771006B1 (en) COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR2771007B1 (en) COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
DZ3320A1 (en) Complex comprising eletriptane and sulphobutylether-cyclodextrin for the treatment of migraine
EP0859761A4 (en) 4-AZASTEROIDES USED FOR THE TREATMENT OF HYPERANDROGENIC CONDITIONS
DE69802498D1 (en) COMBINATION PRODUCT CONTAINING IDEBENON FOR ALZHEIMER TREATMENT
DE60201440D1 (en) ARYL-8-AZABICYCLO [3.2.1] OCTANES FOR THE TREATMENT OF DEPRESSION
EP0687470A3 (en) Agents for the treatment of metabolic bone diseases

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
ST Notification of lapse

Effective date: 20090731